Publications

ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial

21st May 2025 - Structural Heart Disease - The Lancet
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial

16th May 2025 - Coronary Artery Disease (CAD) - EuroIntervention
Cost‑Effectiveness of Ultrasound Renal Denervation for Resistant Hypertension in Belgium, France and The Netherlands

16th April 2025 - Hypertension & Renal Denervation - Other
Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions

4th March 2025 - Coronary Artery Disease (CAD) - Circulation
Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosis

20th January 2025 - Structural Heart Disease - EuroIntervention
Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding Risk

25th November 2024 - Coronary Artery Disease (CAD) - Journal of the American College of Cardiology (JACC)
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial.

2nd November 2024 - Coronary Artery Disease (CAD) - The Lancet
Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent.

1st November 2024 - Coronary Artery Disease (CAD) - American Heart Journal
TCT-381 Safety and Effectiveness of a Novel Intravascular Lithotripsy Device Using the Hertz Contact Stress Mechanism for Calcium Fragmentation: Six-Month Outcomes of the PINNACLE I Clinical Trial

23rd October 2024 - Coronary Artery Disease (CAD) - Journal of the American College of Cardiology (JACC)
One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in women at high-bleeding risk: Insights from the POEM trial

3rd October 2024 - Coronary Artery Disease (CAD) - Catheterization & Cardiovascular Interventions (CCI)

Privacy Policy Legal Notices Cookies Manage cookies

©2025 - Europa Organisation - All rights reserved

top